What is the recommended dose of benzathine penicillin (Bicillin) for treating syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzathine Penicillin Dosing for Syphilis

For early syphilis (primary, secondary, or early latent), administer benzathine penicillin G 2.4 million units intramuscularly as a single dose; for late latent syphilis or syphilis of unknown duration, administer 7.2 million units total as three weekly doses of 2.4 million units each. 1, 2

Adult Dosing by Stage

Early Syphilis (Primary, Secondary, Early Latent)

  • Single dose of 2.4 million units IM is the standard treatment 2, 1
  • Recent high-quality evidence confirms that one dose is noninferior to three doses, with 76% serologic response at 6 months in both regimens 3
  • This single-dose regimen achieves 90-100% treatment success rates 4
  • Administration should be deep intramuscular in the upper outer quadrant of the buttock (dorsogluteal) or ventrogluteal site 1

Late Latent Syphilis or Unknown Duration

  • Total of 7.2 million units administered as three separate doses of 2.4 million units IM at weekly intervals 2, 1
  • Each injection must be spaced exactly 7 days apart 2
  • If a dose is missed, pharmacologic considerations suggest a 10-14 day interval may be acceptable before restarting the sequence, though this is not well-established 2

Neurosyphilis

  • Requires intravenous therapy, not intramuscular benzathine penicillin 5
  • Aqueous crystalline penicillin G 18-24 million units daily (3-4 million units IV every 4 hours) for 10-14 days 5

Pediatric Dosing

Children with Acquired Syphilis (≥1 month old)

  • 50,000 units/kg IM, up to the adult dose of 2.4 million units for early syphilis as a single dose 2
  • For late latent syphilis: 50,000 units/kg IM administered as three doses at weekly intervals (total 150,000 units/kg up to 7.2 million units) 2
  • All children require CSF examination to exclude neurosyphilis before treatment 2

Congenital Syphilis

  • Infants under 2 years: 50,000 units/kg body weight 1
  • Ages 2-12 years: adjust based on adult dosage schedule 1
  • Treatment regimens vary significantly based on maternal treatment history and infant evaluation findings 2

Special Populations

HIV-Infected Patients

  • Use the same single-dose regimen (2.4 million units IM) for early syphilis 2
  • A 2025 randomized trial demonstrated that single-dose therapy was noninferior to three-dose therapy in HIV-infected individuals, with 76% serologic response in the single-dose group versus 71% in the three-dose group 3
  • Earlier 2017 data showed 93% success with single dose versus 100% with three doses in per-protocol analysis, supporting single-dose treatment 6
  • Additional doses do not enhance efficacy regardless of HIV status 2
  • More frequent serologic follow-up (every 3 months) is recommended 7

Pregnant Women

  • Same stage-appropriate penicillin dosing as non-pregnant adults 8, 5
  • For primary, secondary, or early latent: 2.4 million units IM single dose 8
  • Some specialists recommend a second dose of 2.4 million units IM one week later, especially in third trimester or with secondary syphilis 8
  • For late latent or unknown duration: 7.2 million units total as three weekly doses of 2.4 million units 8
  • Penicillin is the only proven effective treatment to prevent mother-to-fetal transmission 8
  • Women with penicillin allergy must undergo desensitization and then receive penicillin—no alternatives are acceptable 8
  • If any dose is missed, the entire course must be repeated 2

Follow-Up and Treatment Response

Serologic Monitoring

  • For early syphilis: clinical and serologic evaluation at 6 and 12 months 2
  • For latent syphilis: repeat quantitative nontreponemal tests at 6,12, and 24 months 2
  • A fourfold decline in titer (two dilutions) is expected within 6 months for primary/secondary syphilis 5
  • Serologic response is generally slower (12-24 months) for latent syphilis 4

Treatment Failure Criteria

  • Titers increase fourfold after initial decline 2
  • Initially high titer (>1:32) fails to decline at least fourfold within 12-24 months 2
  • Signs or symptoms attributable to syphilis develop 2
  • For treatment failure: administer benzathine penicillin G 2.4 million units IM weekly for 3 weeks, unless CSF examination indicates neurosyphilis 2

Critical Pitfalls to Avoid

  • Never use tetracyclines, doxycycline, or erythromycin in pregnant women—these do not prevent congenital syphilis 8
  • Do not inject benzathine penicillin intravenously, into or near an artery or nerve, or admix with other IV solutions 1
  • Avoid administration in the anterolateral thigh due to adverse effects; use dorsogluteal or ventrogluteal sites instead 1
  • Do not assume that persistent low-titer reactivity (serofast state) necessarily indicates treatment failure—a significant proportion of patients remain seropositive despite adequate treatment 7, 4
  • Never compare titers between different test types (VDRL vs RPR) as they are not directly comparable 7
  • Inject at a slow, steady rate to prevent needle blockage due to high concentration of suspended material 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Treatment of Secondary Syphilis Relapse and Reinfection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.